The “Cell-Free DNA (cf-DNA) Testing Industry Forecast” looks at past sales and reviews total world Cell-Free DNA (cf-DNA) Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Cell-Free DNA (cf-DNA) Testing sales for 2023 through 2029. With Cell-Free DNA (cf-DNA) Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell-Free DNA (cf-DNA) Testing industry.
This Insight Report provides a comprehensive analysis of the global Cell-Free DNA (cf-DNA) Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cell-Free DNA (cf-DNA) Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell-Free DNA (cf-DNA) Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell-Free DNA (cf-DNA) Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell-Free DNA (cf-DNA) Testing.
The global Cell-Free DNA (cf-DNA) Testing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Cell-Free DNA (cf-DNA) Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cell-Free DNA (cf-DNA) Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cell-Free DNA (cf-DNA) Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cell-Free DNA (cf-DNA) Testing players cover Agilent Technology, Allenex, Biocept, Biodesix, CareDx, Guardant Health, Illumania, Invited and Natera, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell-Free DNA (cf-DNA) Testing market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Donor-derived
Circulating
Cell-free
Segmentation by application
Oncology
Gynecology
Transplantation
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Agilent Technology
Allenex
Biocept
Biodesix
CareDx
Guardant Health
Illumania
Invited
Natera
Quest Diagnostics
Roche
Sequenom
Trovagene
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cell-Free DNA (cf-DNA) Testing Market Size 2018-2029
2.1.2 Cell-Free DNA (cf-DNA) Testing Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Cell-Free DNA (cf-DNA) Testing Segment by Type
2.2.1 Donor-derived
2.2.2 Circulating
2.2.3 Cell-free
2.3 Cell-Free DNA (cf-DNA) Testing Market Size by Type
2.3.1 Cell-Free DNA (cf-DNA) Testing Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Cell-Free DNA (cf-DNA) Testing Market Size Market Share by Type (2018-2023)
2.4 Cell-Free DNA (cf-DNA) Testing Segment by Application
2.4.1 Oncology
2.4.2 Gynecology
2.4.3 Transplantation
2.5 Cell-Free DNA (cf-DNA) Testing Market Size by Application
2.5.1 Cell-Free DNA (cf-DNA) Testing Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Cell-Free DNA (cf-DNA) Testing Market Size Market Share by Application (2018-2023)
3 Cell-Free DNA (cf-DNA) Testing Market Size by Player
3.1 Cell-Free DNA (cf-DNA) Testing Market Size Market Share by Players
3.1.1 Global Cell-Free DNA (cf-DNA) Testing Revenue by Players (2018-2023)
3.1.2 Global Cell-Free DNA (cf-DNA) Testing Revenue Market Share by Players (2018-2023)
3.2 Global Cell-Free DNA (cf-DNA) Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Cell-Free DNA (cf-DNA) Testing by Regions
4.1 Cell-Free DNA (cf-DNA) Testing Market Size by Regions (2018-2023)
4.2 Americas Cell-Free DNA (cf-DNA) Testing Market Size Growth (2018-2023)
4.3 APAC Cell-Free DNA (cf-DNA) Testing Market Size Growth (2018-2023)
4.4 Europe Cell-Free DNA (cf-DNA) Testing Market Size Growth (2018-2023)
4.5 Middle East & Africa Cell-Free DNA (cf-DNA) Testing Market Size Growth (2018-2023)
5 Americas
5.1 Americas Cell-Free DNA (cf-DNA) Testing Market Size by Country (2018-2023)
5.2 Americas Cell-Free DNA (cf-DNA) Testing Market Size by Type (2018-2023)
5.3 Americas Cell-Free DNA (cf-DNA) Testing Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell-Free DNA (cf-DNA) Testing Market Size by Region (2018-2023)
6.2 APAC Cell-Free DNA (cf-DNA) Testing Market Size by Type (2018-2023)
6.3 APAC Cell-Free DNA (cf-DNA) Testing Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Cell-Free DNA (cf-DNA) Testing by Country (2018-2023)
7.2 Europe Cell-Free DNA (cf-DNA) Testing Market Size by Type (2018-2023)
7.3 Europe Cell-Free DNA (cf-DNA) Testing Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cell-Free DNA (cf-DNA) Testing by Region (2018-2023)
8.2 Middle East & Africa Cell-Free DNA (cf-DNA) Testing Market Size by Type (2018-2023)
8.3 Middle East & Africa Cell-Free DNA (cf-DNA) Testing Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Cell-Free DNA (cf-DNA) Testing Market Forecast
10.1 Global Cell-Free DNA (cf-DNA) Testing Forecast by Regions (2024-2029)
10.1.1 Global Cell-Free DNA (cf-DNA) Testing Forecast by Regions (2024-2029)
10.1.2 Americas Cell-Free DNA (cf-DNA) Testing Forecast
10.1.3 APAC Cell-Free DNA (cf-DNA) Testing Forecast
10.1.4 Europe Cell-Free DNA (cf-DNA) Testing Forecast
10.1.5 Middle East & Africa Cell-Free DNA (cf-DNA) Testing Forecast
10.2 Americas Cell-Free DNA (cf-DNA) Testing Forecast by Country (2024-2029)
10.2.1 United States Cell-Free DNA (cf-DNA) Testing Market Forecast
10.2.2 Canada Cell-Free DNA (cf-DNA) Testing Market Forecast
10.2.3 Mexico Cell-Free DNA (cf-DNA) Testing Market Forecast
10.2.4 Brazil Cell-Free DNA (cf-DNA) Testing Market Forecast
10.3 APAC Cell-Free DNA (cf-DNA) Testing Forecast by Region (2024-2029)
10.3.1 China Cell-Free DNA (cf-DNA) Testing Market Forecast
10.3.2 Japan Cell-Free DNA (cf-DNA) Testing Market Forecast
10.3.3 Korea Cell-Free DNA (cf-DNA) Testing Market Forecast
10.3.4 Southeast Asia Cell-Free DNA (cf-DNA) Testing Market Forecast
10.3.5 India Cell-Free DNA (cf-DNA) Testing Market Forecast
10.3.6 Australia Cell-Free DNA (cf-DNA) Testing Market Forecast
10.4 Europe Cell-Free DNA (cf-DNA) Testing Forecast by Country (2024-2029)
10.4.1 Germany Cell-Free DNA (cf-DNA) Testing Market Forecast
10.4.2 France Cell-Free DNA (cf-DNA) Testing Market Forecast
10.4.3 UK Cell-Free DNA (cf-DNA) Testing Market Forecast
10.4.4 Italy Cell-Free DNA (cf-DNA) Testing Market Forecast
10.4.5 Russia Cell-Free DNA (cf-DNA) Testing Market Forecast
10.5 Middle East & Africa Cell-Free DNA (cf-DNA) Testing Forecast by Region (2024-2029)
10.5.1 Egypt Cell-Free DNA (cf-DNA) Testing Market Forecast
10.5.2 South Africa Cell-Free DNA (cf-DNA) Testing Market Forecast
10.5.3 Israel Cell-Free DNA (cf-DNA) Testing Market Forecast
10.5.4 Turkey Cell-Free DNA (cf-DNA) Testing Market Forecast
10.5.5 GCC Countries Cell-Free DNA (cf-DNA) Testing Market Forecast
10.6 Global Cell-Free DNA (cf-DNA) Testing Forecast by Type (2024-2029)
10.7 Global Cell-Free DNA (cf-DNA) Testing Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Agilent Technology
11.1.1 Agilent Technology Company Information
11.1.2 Agilent Technology Cell-Free DNA (cf-DNA) Testing Product Offered
11.1.3 Agilent Technology Cell-Free DNA (cf-DNA) Testing Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Agilent Technology Main Business Overview
11.1.5 Agilent Technology Latest Developments
11.2 Allenex
11.2.1 Allenex Company Information
11.2.2 Allenex Cell-Free DNA (cf-DNA) Testing Product Offered
11.2.3 Allenex Cell-Free DNA (cf-DNA) Testing Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Allenex Main Business Overview
11.2.5 Allenex Latest Developments
11.3 Biocept
11.3.1 Biocept Company Information
11.3.2 Biocept Cell-Free DNA (cf-DNA) Testing Product Offered
11.3.3 Biocept Cell-Free DNA (cf-DNA) Testing Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Biocept Main Business Overview
11.3.5 Biocept Latest Developments
11.4 Biodesix
11.4.1 Biodesix Company Information
11.4.2 Biodesix Cell-Free DNA (cf-DNA) Testing Product Offered
11.4.3 Biodesix Cell-Free DNA (cf-DNA) Testing Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Biodesix Main Business Overview
11.4.5 Biodesix Latest Developments
11.5 CareDx
11.5.1 CareDx Company Information
11.5.2 CareDx Cell-Free DNA (cf-DNA) Testing Product Offered
11.5.3 CareDx Cell-Free DNA (cf-DNA) Testing Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 CareDx Main Business Overview
11.5.5 CareDx Latest Developments
11.6 Guardant Health
11.6.1 Guardant Health Company Information
11.6.2 Guardant Health Cell-Free DNA (cf-DNA) Testing Product Offered
11.6.3 Guardant Health Cell-Free DNA (cf-DNA) Testing Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Guardant Health Main Business Overview
11.6.5 Guardant Health Latest Developments
11.7 Illumania
11.7.1 Illumania Company Information
11.7.2 Illumania Cell-Free DNA (cf-DNA) Testing Product Offered
11.7.3 Illumania Cell-Free DNA (cf-DNA) Testing Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Illumania Main Business Overview
11.7.5 Illumania Latest Developments
11.8 Invited
11.8.1 Invited Company Information
11.8.2 Invited Cell-Free DNA (cf-DNA) Testing Product Offered
11.8.3 Invited Cell-Free DNA (cf-DNA) Testing Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Invited Main Business Overview
11.8.5 Invited Latest Developments
11.9 Natera
11.9.1 Natera Company Information
11.9.2 Natera Cell-Free DNA (cf-DNA) Testing Product Offered
11.9.3 Natera Cell-Free DNA (cf-DNA) Testing Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Natera Main Business Overview
11.9.5 Natera Latest Developments
11.10 Quest Diagnostics
11.10.1 Quest Diagnostics Company Information
11.10.2 Quest Diagnostics Cell-Free DNA (cf-DNA) Testing Product Offered
11.10.3 Quest Diagnostics Cell-Free DNA (cf-DNA) Testing Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Quest Diagnostics Main Business Overview
11.10.5 Quest Diagnostics Latest Developments
11.11 Roche
11.11.1 Roche Company Information
11.11.2 Roche Cell-Free DNA (cf-DNA) Testing Product Offered
11.11.3 Roche Cell-Free DNA (cf-DNA) Testing Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Roche Main Business Overview
11.11.5 Roche Latest Developments
11.12 Sequenom
11.12.1 Sequenom Company Information
11.12.2 Sequenom Cell-Free DNA (cf-DNA) Testing Product Offered
11.12.3 Sequenom Cell-Free DNA (cf-DNA) Testing Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Sequenom Main Business Overview
11.12.5 Sequenom Latest Developments
11.13 Trovagene
11.13.1 Trovagene Company Information
11.13.2 Trovagene Cell-Free DNA (cf-DNA) Testing Product Offered
11.13.3 Trovagene Cell-Free DNA (cf-DNA) Testing Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Trovagene Main Business Overview
11.13.5 Trovagene Latest Developments
12 Research Findings and Conclusion
*If Applicable.